Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Lantronix to Report Fiscal 2025 Third Quarter Results on May 8, 2025
-
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting
-
WILDBRAIN ANNOUNCES CONFERENCE CALL FOR ITS FISCAL 2025 Q3 FINANCIAL RESULTS
-
Upbound Group, Inc. Reports First Quarter 2025 Results
-
IDEX Reports First Quarter Results
-
On Belay Health Solutions Announces New Chief Financial Officer (CFO)
-
United Natural Foods Supports Product Personalization and Transparency Through GreenChoice
-
Bidgely Surpasses 1.5 TWh of Energy Savings, Offsetting 1M Tons of CO2 Emissions
-
McDONALD'S REPORTS FIRST QUARTER 2025 RESULTS
-
Tessen Investment Education Center: Pioneering a New Era of AI Trading Education, Empowering the Future of Global Investments
-
Perfect Corp. CEO Alice Chang Honored with Game-Changer Award at 2025 CEW Achiever Awards
-
Li-Cycle Undertaking Process to Seek Buyers for its Business or Assets
-
Air2O Expands New Phoenix Manufacturing Facility Fivefold, Plans to Create Over 200 Jobs
-
NationsBenefits Helps Enhance Hearing Health Outcomes with Member Access and Affordability
-
Modern Health Challenges Outdated Employee Assistance Programs With The Launch of FlexEAP by Modern Health(SM)
-
Origin Materials Announces First Quarter 2025 Earnings Release Date and Conference Call
-
Armata Pharmaceuticals Receives $4.65 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support Ongoing diSArm Clinical Trial of AP-SA02
-
Organon Reports Results for the First Quarter Ended March 31, 2025
-
TEN (Transportation Equipment Network) Launches TEN Ready: A Disaster Recovery Initiative Built on Rapid Response and Resilient Partnerships
-
Oil States Announces First Quarter 2025 Results
-
Alkermes plc Reports First Quarter 2025 Financial Results
-
Atea Pharmaceuticals to Host Virtual HCV KOL Panel on May 14, 2025
-
Latest Data from SURPASS-3 Trial Gleans Insight Into the Association of Tirzepatide Treatment with Changes in Muscle Composition in Type 2 Diabetes
-
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
-
Builders FirstSource Reports First Quarter 2025 Results
-
Older Americans Are Redefining Romance Online, New Data from DateMyAge
-
Dembo Jones to join CLA on May 1
-
Newly Launched DCx Biotherapeutics In-Licenses Discovery Platforms and Retains Talent and Infrastructure From Repare Therapeutics to Accelerate Development of Multi-Modal Antibody Drug Conjugates
-
BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
-
Identiv and InPlay Introduce Next-Generation BLE-Enabled Smart Labels for Industrial IoT Applications
-
OneWater Marine Inc. Announces Fiscal Second Quarter Results
-
Orezone Provides Update on RCF Block Trade to Australian Funds
-
Treasure Data Achieves Google Cloud Ready - BigQuery Designation
-
Eptura Achieves FedRAMP® Authorization for its Integrated Workplace Management System
-
Stowers Investigator elected to the National Academy of Sciences
-
BDR announces Profit Launch business planning workshops for home service companies
-
PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference
-
Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
-
Bladder Cancer Awareness Month Kicks Off: Knowledge Can Save Lives
-
Data Communications Management Corp. Announces Publication of Company’s 2024 Sustainability Report
-
Affinity Group Launches New Podcast, "Your Bridge to Local," Spotlighting Innovation and Insights Across the Foodservice Industry
-
Natera to Report its First Quarter Results on May 8, 2025
-
Canada Goose to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on May 21, 2025
-
Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
-
CryptoSlots Celebrates 7 Years with New Safari Sunsets Slot and Big Bonuses
-
ZYUS Life Sciences Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent covering Trichomylin® Formulation and Announces Unit Offering
-
Builders FirstSource Announces $500 Million Share Repurchase Authorization
-
FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain
-
Enthusiast Gaming’s U.GG Expands Analytics Platform to Support Rainbow Six Siege
-
Aduro Engages Siemens to Deliver Advanced Automation for Hydrochemolytic™ Pilot Plant

